The Cdc42/Rac1 pathway: a molecular mechanism behind iron-deficiency-driven aortic medial degeneration.
Abstract
[OBJECTIVE] To elucidate the underlying mechanism of iron deficiency augmented Angiotensin II-induced aortic medial degeneration.
[METHODS] ApoE mice were randomly divided into four groups: normal control group (NC group), Angiotensin II (Ang II) subcutaneous pumped alone Group (Ang II group), iron deficiency (ID) group (ID group) and ID+Ang II group. The survival time, systolic blood pressure (SBP), and aortic medial degeneration (AMD) formation were monitored. Iron deposition in the aortas was assessed using Prussian blue iron staining. The expression of iron metabolism indicators, aortopathies and the cytoskeleton of vascular smooth muscle cells (VSMCs) were analyzed. In an in vitro setting, deferoxamine (DFO) was employed to mimic ID to examine the effects of Ang II on the cytoskeletal and contractile function of VSMCs during ID. Ras-related C3 botulinum toxin substrate 1 (Rac-1) expression was inhibited with EHT1864 to verify the role of Cdc42/Rac1 pathway in this pathological process. Blood samples were collected from 150 patients with aortic dissection (AD) and 60 patients with hypertension who were admitted to the Department of Cardiovascular Surgery at Renmin Hospital of Wuhan University between June 2018 and September 2019. The aortic tissues were obtained during the surgical treatment of Stanford type A AD patients and the heart donor. The iron metabolism status in plasma and aortic tissue was analyzed.
[RESULTS] In vivo experiments revealed that, in comparison to the NC and ID groups, mice in the Ang II and ID+Ang II groups exhibited increased SBP, significantly reduced survival time, and an expanded range of aortic dissection (P < 0.05). ID feeding augmented the Ang II-induced aortopathies. Both in vitro and in vivo results indicated that ID led to diminished expression of phosphorylated myosin light chain (p-MLC) and recombinant Cell Division Cycle Protein 42 (Cdc42) in VSMCs, while Rac-1 expression increased. The clinical sample testing data further confirmed the discovery that individuals diagnosed with AD display ID in both the plasma and the diseased aortas.
[CONCLUSIONS] The Cdc42/Rac1 pathway plays a crucial role in disrupting the cytoskeleton of vascular smooth muscle cells during iron deficiency, which leads to aortic medial degeneration both in vivo and in vitro.
[METHODS] ApoE mice were randomly divided into four groups: normal control group (NC group), Angiotensin II (Ang II) subcutaneous pumped alone Group (Ang II group), iron deficiency (ID) group (ID group) and ID+Ang II group. The survival time, systolic blood pressure (SBP), and aortic medial degeneration (AMD) formation were monitored. Iron deposition in the aortas was assessed using Prussian blue iron staining. The expression of iron metabolism indicators, aortopathies and the cytoskeleton of vascular smooth muscle cells (VSMCs) were analyzed. In an in vitro setting, deferoxamine (DFO) was employed to mimic ID to examine the effects of Ang II on the cytoskeletal and contractile function of VSMCs during ID. Ras-related C3 botulinum toxin substrate 1 (Rac-1) expression was inhibited with EHT1864 to verify the role of Cdc42/Rac1 pathway in this pathological process. Blood samples were collected from 150 patients with aortic dissection (AD) and 60 patients with hypertension who were admitted to the Department of Cardiovascular Surgery at Renmin Hospital of Wuhan University between June 2018 and September 2019. The aortic tissues were obtained during the surgical treatment of Stanford type A AD patients and the heart donor. The iron metabolism status in plasma and aortic tissue was analyzed.
[RESULTS] In vivo experiments revealed that, in comparison to the NC and ID groups, mice in the Ang II and ID+Ang II groups exhibited increased SBP, significantly reduced survival time, and an expanded range of aortic dissection (P < 0.05). ID feeding augmented the Ang II-induced aortopathies. Both in vitro and in vivo results indicated that ID led to diminished expression of phosphorylated myosin light chain (p-MLC) and recombinant Cell Division Cycle Protein 42 (Cdc42) in VSMCs, while Rac-1 expression increased. The clinical sample testing data further confirmed the discovery that individuals diagnosed with AD display ID in both the plasma and the diseased aortas.
[CONCLUSIONS] The Cdc42/Rac1 pathway plays a crucial role in disrupting the cytoskeleton of vascular smooth muscle cells during iron deficiency, which leads to aortic medial degeneration both in vivo and in vitro.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | subcutaneous
|
피하조직 | dict | 1 | |
| 해부 | medial
|
scispacy | 1 | ||
| 해부 | systolic blood pressure
|
scispacy | 1 | ||
| 해부 | aortic medial
|
scispacy | 1 | ||
| 해부 | aortas
|
scispacy | 1 | ||
| 해부 | cytoskeleton
|
scispacy | 1 | ||
| 해부 | vascular smooth muscle cells
|
scispacy | 1 | ||
| 해부 | VSMCs
→ vascular smooth muscle cells
|
scispacy | 1 | ||
| 해부 | cytoskeletal
|
scispacy | 1 | ||
| 해부 | contractile
|
scispacy | 1 | ||
| 해부 | Cardiovascular
|
scispacy | 1 | ||
| 해부 | aortic tissues
|
scispacy | 1 | ||
| 해부 | heart
|
scispacy | 1 | ||
| 해부 | plasma
|
scispacy | 1 | ||
| 해부 | aortic tissue
|
scispacy | 1 | ||
| 해부 | SBP
→ systolic blood pressure
|
scispacy | 1 | ||
| 해부 | Cell
|
scispacy | 1 | ||
| 약물 | iron
|
C0302583
iron
|
scispacy | 1 | |
| 약물 | Angiotensin
|
C0003018
Angiotensins
|
scispacy | 1 | |
| 약물 | Angiotensin II
|
C0003009
angiotensin II
|
scispacy | 1 | |
| 약물 | Prussian blue iron
|
scispacy | 1 | ||
| 약물 | deferoxamine
|
C0011145
deferoxamine
|
scispacy | 1 | |
| 약물 | DFO
→ deferoxamine
|
C0011145
deferoxamine
|
scispacy | 1 | |
| 약물 | EHT1864
|
C1664218
EHT 1864
|
scispacy | 1 | |
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | Prussian
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | aortic medial degeneration
|
scispacy | 1 | ||
| 질환 | AMD
→ aortic medial degeneration
|
scispacy | 1 | ||
| 질환 | hypertension
|
C0020538
Hypertensive disease
|
scispacy | 1 | |
| 질환 | SBP
→ systolic blood pressure
|
scispacy | 1 | ||
| 질환 | Blood samples
|
scispacy | 1 | ||
| 기타 | Cdc42/Rac1
|
scispacy | 1 | ||
| 기타 | Angiotensin II-induced aortic
|
scispacy | 1 | ||
| 기타 | Angiotensin II
|
scispacy | 1 | ||
| 기타 | Ang II
→ Angiotensin II
|
scispacy | 1 | ||
| 기타 | Rac-1
→ Ras-related C3 botulinum toxin substrate 1
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | mice
|
scispacy | 1 | ||
| 기타 | myosin light chain
|
scispacy | 1 | ||
| 기타 | Cdc42
→ Cell Division Cycle Protein 42
|
scispacy | 1 | ||
| 기타 | aortas
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.